Breaking New Ground: FDA Approves Groundbreaking Schizophrenia Treatment KarXT
In a landmark decision, the Food and Drug Administration (FDA) has given its seal of approval to KarXT, a revolutionary new treatment for schizophrenia. This groundbreaking medication, developed by Bristol Myers Squibb, marks a significant turning point in the fight against this devastating mental health disorder. Continue reading “FDA approves new schizophrenia treatment KarXT”